Goldman Sachs’s Structure Therapeutics GPCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.57M | Sell |
220,174
-104,261
| -32% | -$2.16M | ﹤0.01% | 2878 |
|
|
2025
Q1 | $5.62M | Sell |
324,435
-258,430
| -44% | -$4.47M | ﹤0.01% | 2657 |
|
|
2024
Q4 | $15.8M | Sell |
582,865
-129,930
| -18% | -$3.52M | ﹤0.01% | 1969 |
|
|
2024
Q3 | $31.3M | Buy |
712,795
+30,432
| +4% | +$1.34M | 0.01% | 1399 |
|
|
2024
Q2 | $26.8M | Buy |
682,363
+233,692
| +52% | +$9.18M | ﹤0.01% | 1378 |
|
|
2024
Q1 | $19.2M | Buy |
448,671
+20,936
| +5% | +$897K | ﹤0.01% | 1575 |
|
|
2023
Q4 | $17.4M | Buy |
427,735
+356,302
| +499% | +$14.5M | ﹤0.01% | 1668 |
|
|
2023
Q3 | $3.6M | Buy |
+71,433
| New | +$3.6M | ﹤0.01% | 2717 |
|